Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 60 Breast Neoplasms 21 Neoplasms 19 Fallopian Tube Neoplasms 16 Prostatic Neoplasms 15 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Glioblastoma 7 Triple Negative Breast Neoplasms 6 Lung Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Glioma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Mesothelioma 3 Melanoma 3 Head and Neck Neoplasms 3 Cystadenocarcinoma, Serous 3 Cholangiocarcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Stomach Neoplasms 2 Solid Tumor 2 Sarcoma 2 Prostatic Neoplasms, Castration-Resistant 2 Ovarian Diseases 2 Mesothelioma, Malignant 2

Interventions

anlotinib 2 niraparib 1 afuresertib 1 Paclitaxel 1 PHI-101 1 Gemcitabine 1 ALT-803 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Platinum-resistant Ovarian Cancer × niraparib × Clear all

NCT04376073 2020-11-25

ANNIE

Sun Yat-sen University

Phase 2 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡